247 filings
8-K
SGEN
Seagen Inc.
14 Dec 23
Completion of Acquisition or Disposition of Assets
8:00am
8-K
SGEN
Seagen Inc.
12 Dec 23
Other Events
8:32am
8-K
SGEN
Seagen Inc.
1 Nov 23
Seagen Third Quarter 2023 Financial Results Reflect Strong Product Sales Growth, and Significant Portfolio and Pipeline Progress
8:09am
8-K
SGEN
Seagen Inc.
19 Oct 23
Other Events
11:14am
8-K
SGEN
Seagen Inc.
22 Sep 23
Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal
6:05am
8-K
5kl6zk1ms44eb26ym
5 Sep 23
Improved Overall Survival in Patients With Recurrent or Metastatic Cervical Cancer Compared With Chemotherapy Alone
6:07am
8-K
ulxmv zv7c
16 Aug 23
Other Events
8:15am
8-K
uyek3oi3 ar0
2 Aug 23
Results of Operations and Financial Condition
8:11am
8-K
1wtwipl
14 Jul 23
Other Events
5:15pm
8-K
ym1004s6793lfzs9wxu
14 Jun 23
Other Events
6:05am
8-K
t3ns92zq
1 Jun 23
Submission of Matters to a Vote of Security Holders
8:11am
8-K
gv840
31 May 23
Seagen Stockholders Approve Acquisition by Pfizer
5:25pm
8-K
98p3nwrbqy 5s
23 May 23
Other Events
6:06am
8-K
v1err24lk5dn57x
15 May 23
Other Events
6:15am
8-K
86jjspi
27 Apr 23
Seagen Reports First Quarter 2023 Financial Results
8:10am
8-K
gu9h gpfu07ci8omn
3 Apr 23
Other Events
5:26pm
8-K
uv5b6gl9j6zl3 1zxij
13 Mar 23
Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion
7:27am
8-K
bfowqgc
15 Feb 23
Seagen Reports Fourth Quarter and Full Year 2022 Financial Results
4:11pm
8-K
f7sd8i
19 Jan 23
Other Events
3:37pm
8-K
ychngv8w c0t8mw14wum
18 Nov 22
Amendments to Articles of Incorporation or Bylaws
4:47pm